Cargando…
Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line
INTRODUCTION: Germline mutations in the breast and ovarian cancer susceptibility gene BRCA1, which is located on chromosome 17q21, are associated with a predisposition to the development of cancer in these organs [1,2]. No mutations in the BRCA1 gene have been detected in sporadic breast cancer case...
Autores principales: | Annab, Lois A, Hawkins, Rebecca E, Solomon, Greg, Barrett, J Carl, Afshari, Cynthia A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13916/ https://www.ncbi.nlm.nih.gov/pubmed/11056686 |
Ejemplares similares
-
Transactivation of the estrogen receptor promoter by BRCA1
por: Archey, William B., et al.
Publicado: (2017) -
Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations
por: Tulchin, Natalie, et al.
Publicado: (2013) -
BRCA1 Zinc RING Finger Domain Disruption Alters Caspase Response in Ovarian Surface Epithelial Cells
por: Johnson, Nicole C, et al.
Publicado: (2002) -
The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells
por: Weberpals, Johanne I, et al.
Publicado: (2011) -
BRCA1 and BRCA2 mutations and clinical interpretation in 398 ovarian cancer patients: comparison with breast cancer variants in a similar population
por: Cardoso, Florencia C., et al.
Publicado: (2018)